Mim8
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Haemophilia A With or Without Inhibitors
Conditions
Haemophilia A With or Without Inhibitors
Trial Timeline
Apr 4, 2022 → Nov 13, 2024
NCT ID
NCT05306418About Mim8
Mim8 is a phase 3 stage product being developed by Novo Nordisk for Haemophilia A With or Without Inhibitors. The current trial status is completed. This product is registered under clinical trial identifier NCT05306418. Target conditions include Haemophilia A With or Without Inhibitors.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05685238 | Phase 3 | Active |
| NCT05306418 | Phase 3 | Completed |
Competing Products
20 competing products in Haemophilia A With or Without Inhibitors
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mim8 | Novo Nordisk | Phase 3 | 76 |
| Turoctocog alfa | Novo Nordisk | Phase 3 | 76 |
| NNC0365-3769 (Mim8) | Novo Nordisk | Phase 3 | 76 |
| Turoctocog alfa pegol | Novo Nordisk | Pre-clinical | 22 |
| Mim8 B, 10 mg/mL + Mim8 B, 100 mg/mL + Mim8 B, placebo | Novo Nordisk | Phase 1 | 32 |
| Turoctocog alfa pegol | Novo Nordisk | Pre-clinical | 22 |
| Concizumab | Novo Nordisk | Phase 3 | 76 |
| Concizumab | Novo Nordisk | Phase 3 | 76 |
| turoctocog alfa pegol (N8-GP) | Novo Nordisk | Phase 3 | 76 |
| Concizumab | Novo Nordisk | Phase 3 | 76 |
| Esperoct | Novo Nordisk | Pre-clinical | 22 |
| NNC0442-0344 A | Novo Nordisk | Phase 1 | 32 |
| NNC0365-3769 (Mim8) PPX | Novo Nordisk | Phase 3 | 76 |
| Concizumab | Novo Nordisk | Pre-clinical | 22 |
| Refixia® | Novo Nordisk | Pre-clinical | 22 |
| NNC0442-0344 A + Placebo | Novo Nordisk | Phase 1 | 32 |
| Turoctocog alfa pegol (N8-GP) | Novo Nordisk | Pre-clinical | 22 |
| Nonacog beta pegol | Novo Nordisk | Pre-clinical | 22 |
| Concizumab | Novo Nordisk | Pre-clinical | 22 |
| Turoctocog alfa | Novo Nordisk | Pre-clinical | 22 |